跳至主要内容
临床试验/NCT02746445
NCT02746445已完成不适用

A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)

Wave Neuroscience1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11
试验地点
1
主要终点
Change in Childhood Autism Rating Scale (CARS)

研究概览

简要总结

The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.

详细描述

This clinical trial is a longitudinal study designed to evaluate the safety and efficacy for subjects with Autism Spectrum Disorder (ASD) who received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in the IRB approved clinical trial. A total of twenty-eight (28) subjects will be followed in this study. After providing informed consent, twenty-eight (28) subjects who participated in the previous protocol will be observed for up to three (3) years post-MeRT treatment. During this period, subjects will be evaluated at 104 and 156 weeks post-MeRT treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subject must have completed the MeRT-001 (formerly known as MRT-001) clinical trial conducted by the Brain Treatment Center (BTC)
  • Age between 6 and 15 years (at day of informed consent)
  • Willing and able to adhere to the study visits

排除标准

  • Subjects who did not participate in the MeRT-001 clinical trial.
  • Any condition which in the judgment of the investigator would prevent the subject from completion of the study.

结局指标

主要结局

Change in Childhood Autism Rating Scale (CARS)

时间窗: Change from baseline CARS score at 104 weeks post-MeRT treatment

Symptom reduction in ASD will be measured using the arithmetic reduction in the CARS total score between two time points BL and week 104 (or Early Termination)

次要结局

  • Childhood Autism Rating Scale (CARS)(Baseline, weeks 5, 10, and 12, and 104 and 156 weeks post-MeRT treatment)

研究者

发起方
Wave Neuroscience
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验